Modulators of urinary pH in the context of urinary stone disease: a literature review.

IF 1.7 3区 医学 Q4 ANDROLOGY
Translational andrology and urology Pub Date : 2025-08-30 Epub Date: 2025-08-26 DOI:10.21037/tau-2025-275
Carter Chan, Wilson Sui, Matthew C Breeggemann, Marshall Stoller
{"title":"Modulators of urinary pH in the context of urinary stone disease: a literature review.","authors":"Carter Chan, Wilson Sui, Matthew C Breeggemann, Marshall Stoller","doi":"10.21037/tau-2025-275","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objective: </strong>Urinary pH is an important factor in the preventative management of kidney stones. A variety of options are available for modulating urinary pH, including pharmaceuticals, over the counter (OTC) formulations [such as stone specific OTCs, complementary and alternative medicines (CAMs), and home remedies], and dietary modifications. These options can be overwhelming for both providers and patients and vary with regards to cost, convenience, and efficacy. In the absence of a consolidated central source of information for patients and physicians to reference, our study aims to summarize and analyze the effectiveness of these various treatment approaches to provide a more comprehensive understanding of how common interventions alter urinary pH.</p><p><strong>Methods: </strong>The PubMed database was used to identify human clinical trials related to pharmacologic and dietary interventions to modify urinary pH. Eligible studies were selected based on the following criteria: (I) observational or interventional study; (II) urinary pH as a reported outcome of the study intervention; (III) inclusion baseline or control urinary pH data; (IV) sufficient presentation of data for analytical purposes. Data was abstracted, and the mean changes in urinary pH for each intervention were compiled and grouped.</p><p><strong>Key content and findings: </strong>A total of 86 studies met inclusion criteria: 61 were randomized clinical trials, 20 were crossover or prospective studies, and 5 were observational cohort reports. In total, 150 individual experiments with a combined sample size of 2,895 were included. For urinary alkalinization, the most effective pharmaceutical, OTC formulation, and dietary change were sodium bicarbonate, Citro-Soda<sup>®</sup>, and lacto-ovo-vegetarian diet, respectively. For urinary acidification, the most effective interventions were ammonium chloride, methionine, and high protein diet, respectively.</p><p><strong>Conclusions: </strong>Our study found that pharmaceuticals are not the only effective options for altering urine pH; select dietary changes and OTC options are also viable for patients. When considering cost, accessibility and side effects, these alternative options may be more appealing to some patients, potentially improving adherence compared to pharmaceuticals.</p>","PeriodicalId":23270,"journal":{"name":"Translational andrology and urology","volume":"14 8","pages":"2428-2438"},"PeriodicalIF":1.7000,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12433178/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational andrology and urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/tau-2025-275","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/26 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ANDROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and objective: Urinary pH is an important factor in the preventative management of kidney stones. A variety of options are available for modulating urinary pH, including pharmaceuticals, over the counter (OTC) formulations [such as stone specific OTCs, complementary and alternative medicines (CAMs), and home remedies], and dietary modifications. These options can be overwhelming for both providers and patients and vary with regards to cost, convenience, and efficacy. In the absence of a consolidated central source of information for patients and physicians to reference, our study aims to summarize and analyze the effectiveness of these various treatment approaches to provide a more comprehensive understanding of how common interventions alter urinary pH.

Methods: The PubMed database was used to identify human clinical trials related to pharmacologic and dietary interventions to modify urinary pH. Eligible studies were selected based on the following criteria: (I) observational or interventional study; (II) urinary pH as a reported outcome of the study intervention; (III) inclusion baseline or control urinary pH data; (IV) sufficient presentation of data for analytical purposes. Data was abstracted, and the mean changes in urinary pH for each intervention were compiled and grouped.

Key content and findings: A total of 86 studies met inclusion criteria: 61 were randomized clinical trials, 20 were crossover or prospective studies, and 5 were observational cohort reports. In total, 150 individual experiments with a combined sample size of 2,895 were included. For urinary alkalinization, the most effective pharmaceutical, OTC formulation, and dietary change were sodium bicarbonate, Citro-Soda®, and lacto-ovo-vegetarian diet, respectively. For urinary acidification, the most effective interventions were ammonium chloride, methionine, and high protein diet, respectively.

Conclusions: Our study found that pharmaceuticals are not the only effective options for altering urine pH; select dietary changes and OTC options are also viable for patients. When considering cost, accessibility and side effects, these alternative options may be more appealing to some patients, potentially improving adherence compared to pharmaceuticals.

Abstract Image

尿路结石疾病背景下的尿pH调节剂:文献综述。
背景与目的:尿pH值是预防肾结石的一个重要因素。调节尿液pH值有多种选择,包括药物、非处方(OTC)制剂(如针对结石的OTC、补充和替代药物(CAMs)和家庭疗法)和饮食调整。这些选择对提供者和患者来说都是压倒性的,并且在成本、便利性和疗效方面各不相同。在缺乏统一的中心信息来源供患者和医生参考的情况下,我们的研究旨在总结和分析这些不同治疗方法的有效性,以便更全面地了解常见干预措施如何改变尿ph值。PubMed数据库用于确定与药物和饮食干预有关的人类临床试验,以改变尿ph值。根据以下标准选择符合条件的研究:(1)观察性或介入性研究;(II)尿pH值作为研究干预的报告结果;(III)纳入基线或对照尿液pH值数据;(IV)为分析目的提供充分的数据。对数据进行提取,并对各干预措施的尿pH值的平均变化进行汇总和分组。主要内容和发现:86项研究符合纳入标准:61项为随机临床试验,20项为交叉或前瞻性研究,5项为观察性队列研究。总共包括150个单独的实验,总样本量为2,895。对于尿碱化,最有效的药物、OTC配方和饮食改变分别是碳酸氢钠、cittro - soda®和乳蛋素饮食。对于尿酸化,最有效的干预措施分别是氯化铵、蛋氨酸和高蛋白饮食。结论:我们的研究发现药物不是改变尿液pH值的唯一有效选择;选择性饮食改变和非处方药对患者也是可行的。当考虑到成本、可及性和副作用时,这些替代方案可能对一些患者更有吸引力,与药物相比,可能会提高依从性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.10
自引率
5.00%
发文量
80
期刊介绍: ranslational Andrology and Urology (Print ISSN 2223-4683; Online ISSN 2223-4691; Transl Androl Urol; TAU) is an open access, peer-reviewed, bi-monthly journal (quarterly published from Mar.2012 - Dec. 2014). The main focus of the journal is to describe new findings in the field of translational research of Andrology and Urology, provides current and practical information on basic research and clinical investigations of Andrology and Urology. Specific areas of interest include, but not limited to, molecular study, pathology, biology and technical advances related to andrology and urology. Topics cover range from evaluation, prevention, diagnosis, therapy, prognosis, rehabilitation and future challenges to urology and andrology. Contributions pertinent to urology and andrology are also included from related fields such as public health, basic sciences, education, sociology, and nursing.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信